Evan Seigerman, BMO Capital Markets, joins ‘Fast Money’ to talk to Nono Nordisk sinking on guidance cut.
Novo Nordisk needs something new, outside of weigh-loss drugs, says BMO’s Seigerman
By superadmin
Enter your account data and we will send you a link to reset your password.
Here you'll find all collections you've created before.
